logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yongluo Jiang

Sun Yat-sen University Cancer Center
H指数:9
被引数:340

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis

AQP4和MOG表征检查点阻断诱导性视神经炎的自身抗体谱

Annals of Neurology
IF7.7
2026-07-290
PRE
Tong Wu; Yongluo Jiang; Jiacai Lin; Jingyao Zhang; Ao Zhang; Guanqing Zhong; Guangmin Jian; Yiwei Xu; Pengfei Zhu; Jun Lv; Xiaochang Wu; Yang Liu; Youlong Wang; Yiming Li; Zhenyun Guo; Ningnan Fang; Xinjia Wang; Weidong Wang; Jun Lu; Ruijie Yao; Xiaoping Hong; Chenyu Yang; Shangeng Weng; Rui Wang; Rui Li; Yifei Ma
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity

与检查点阻断相关的中枢神经系统不良事件特征为具有持续性神经抗原反应性的神经毒性辅助T细胞

Cell Reports Medicine
IF10.6
2026-04-010
OAAI
Ma, Yifei; Zhang, Ao; Lin, Jiacai; Ding, Fadian; Wang, Xinjia; Wang, Weidong; Jian, Guangmin; Zhang, Jingyao; Zhu, Pengfei; Ma, Yue; Lv, Jun; Zheng, Hongjun; Li, Jin; Wu, Tong; Zeng, Jiling; Jiang, Yongluo; Xu, Yiwei; Lyu, Xiajie; Wang, Youlong; Li, Yiming; Liu, Nianqi; Zheng, Zong-Qing; Niu, Yu Si; Guo, Zhenyun; Fang, Ningnan; Jiang, Wei; Wang, Lihong; Chen, Jiahao; Yuan, Mengqin; Huang, Qi; Li, Jinjian; Lu, Jun; Chen, Bocen; Huang, Tong; Zhong, Guanqing; Li, Rui; Liu, Haizhou; Weng, Shangeng
Phenotypes and cytokines of NK cells in triple-negative breast cancer resistant to checkpoint blockade immunotherapy

三阴性乳腺癌对免疫检查点阻断疗法耐药的NK细胞表型及细胞因子

BREAST CANCER RESEARCH
IF5.6
2025-04-030
OA
Wang, Youlong; Jiang, Yongluo; Ding, Fadian; Lu, Jun; Huang, Tong; Zhong, Guanqing; Zhu, Pengfei; Ma, Yue; Li, Jin; Wang, Xinjia; Lin, Jiacai; Zheng, Hongjun; Wang, Weidong; Xu, Yiwei; Lyu, Xiajie; Niu, Yu Si; Qi, Xin; Li, Jinjian; Chen, Bocen; He, Tingting; Zeng, Jiling; Ma, Yifei
Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients

免疫检查点抑制剂和癌症相关认知衰退：化疗活跃期患者中的倾向性评分匹配分析

FRONTIERS IN IMMUNOLOGY
IF5.9
2025-03-070
OA
Jian, Guangmin; Zeng, Jiling; Lu, Jun; Wang, Weidong; Jiang, Yongluo; Huang, Tong; Niu, Yu Si; Chai, Zhoufang; Qi, Xin; Liu, Nianqi; Wang, Youlong; Liu, Cantong; Lin, Jiacai; Zhong, Guanqing; Li, Yiming; Zhu, Pengfei; Zheng, Zong-qing; Ding, Fadian; Wang, Xinjia; Liu, Weizhi; Zhang, Ao
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

通过测量接受PD-1/PD-L1抑制剂治疗的晚期非小细胞肺癌患者中每个器官的单个最大病变来评估肿瘤反应

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2023-10-241
OAAI
He, Li-Na; Chen, Tao; Fu, Sha; Jiang, Yongluo; Zhang, Xuanye; Chen, Chen; Du, Wei; Luo, Linfeng; Li, Anlin; Wang, Yixing; Yu, Hui; Zhou, Yixin; Wang, Yuhong; Yang, Yunpeng; Huang, Yan; Zhao, Hongyun; Fang, Wenfeng; Zhang, Li; Hong, Shaodong

研究方向

暂未获取到该数据
Y
Youlong Wang
H 指数:6论文数:19被引数:105
Y
Yifei Ma
H 指数:33论文数:167被引数:3,478
N
Nianqi Liu
H 指数:11论文数:34被引数:2,221
P
Pengfei Zhu
H 指数:29论文数:129被引数:5,643
X
Xinjia Wang
H 指数:16论文数:70被引数:596
G
Guangmin Jian
H 指数:2论文数:14被引数:27
J
Jiling Zeng
H 指数:9论文数:42被引数:274
Y
Yixin Zhou
H 指数:21论文数:87被引数:1,666
洪
洪少东
H 指数:39论文数:241被引数:7,041
W
Wenfeng Fang
H 指数:47论文数:423被引数:9,805